ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullish•Macquarie Group
•06 Oct 2025 06:54

From Banks to Miners: Cheap Vs. Rich Volatility Across Australia

​Volatility cones help evaluate options trading, showing Australian banks are rich and miners are cheap in December. Spot opportunities and manage...

Logo
541 Views
Share
•02 Sep 2025 12:00•Syndicated

James Hardie Industries Plc - Stockland Firing On All Cylinders

Stockland posted a strong FY25 result and guidance, highlighting growth potential in residential and commercial property, while addressing funding...

Logo
FNArena
404 Views
Share
•28 Aug 2025 15:55

ASX Short Interest Weekly (Aug 22nd): Bluescope Steel, CSL, Wesfarmers, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Bluescope Steel, CSL, Wesfarmers, Northern Star...

Logo
424 Views
Share
bullish•CSL Ltd
•26 Aug 2025 08:30

CSL Ltd (CSL AU): Announces Job Cut and Vaccine Unit Spinout Amid Strong FY25 Financial Performance

CSL announced major strategic initiatives targeting annual cost savings of >$500M by FY28. The initiatives will lead to 15% reduction in CSL’s...

Logo
1k Views
Share
•21 Aug 2025 17:10

ASX Short Interest Weekly (Aug 15th): Liontown Resources, CAR, ANZ, Light & Wonder

We analyzed ASX short interest report for the past week and highlight short interest changes in Liontown Resources, CAR, ANZ, Light & Wonder,...

Logo
439 Views
Share
x